ETAP - Pharmacology, Cancérologie, Nutrition ETAP - Pharmacology, Cancérologie, Nutrition
  The Sence In The Light Of Behavior
 

HOME

ACCESS MAP

CONTACT

INQUIRY FORM

 

  News

 

 Research Centre

 Pharmacology & Ethotoxicology

 Cancerology & Human Pathologies

 Health Nutrition

 References

Research Centre

PRECLINICAL RESEARCH & DEVELOPMENT

ETAP is specialized in preclinical research & development : Neuropharmacology, Psychopharmacology, Cancerology, Health Nutrition and Etho-toxicology. ETAP primarily uses rodents in classical preclinical models and in validated original ones resulting from its own research.
ETAP scientists have extensive experience conducting pharmacological, cancerological and nutritional studies in various preclinical models and by a variety of administration routes (IP, PO, SC, IV).

* Recent Articles

Messaoudi M, Violle N, Bisson JF et al. : Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011 ; 2(4):1-6.

Messaoudi M, Lalonde R, Violle N, Javelot H. et al. : Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011 ; 105(5):755-64.

Javelot T, Javelot H, Baratta A, Weiner L, Messaoudi M, Lemoine P. : Acute psychotic disorders related to bupropion : Review of the literature.Encephale. 2010 ; 36(6):461-471.

Rougeot C, Robert F, Menz L, Bisson JF, Messaoudi M. : Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects. J Physiol Pharmacol. 2010 ;61(4):483-90.

Etap – Preclinical models in psychopharmacology, neuropharmacology, cancerology and  health-nutrition
 

HOME

ACCESS MAP

CONTACT

INQUIRY FORM